K. Flanigan

K. Flanigan's research focuses on Duchenne Muscular Dystrophy (DMD), a genetic muscle-wasting disease, with particular attention to experimental treatments such as exon-skipping therapies and drugs that help cells read through certain genetic mutations. Their work includes clinical trial results testing these therapies' effects on dystrophin (a protein missing or reduced in DMD patients) and on muscle health. This research is relevant to students interested in genetic neuromuscular disorders and translational clinical trials for rare diseases.

Publication output has remained fairly steady over the last decade, with small fluctuations between 1 and 3 papers per year and no clear upward or downward trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026